Calbee, Inc. (CBCFF)

Theseus Pharmaceuticals Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	34,998	56,755	44,295	32,167	35,005	34,572
Short-Term Investments	15,142	-	-	-	23,999	38,899
Cash & Short-Term Investments	50,140	56,755	44,295	32,167	59,004	73,471
Cash Growth	12.39%	28.13%	37.70%	-45.48%	-19.69%	-0.12%
Receivables	38,877	41,496	54,040	37,010	32,576	30,444
Inventory	26,656	25,136	22,208	23,352	18,001	14,694
Other Current Assets	5,986	10,450	7,310	6,441	5,590	4,868
Total Current Assets	121,659	133,837	127,853	98,970	115,171	123,477
Property, Plant & Equipment	146,349	145,782	123,657	101,533	82,979	77,280
Long-Term Investments	14,848	10,276	9,968	7,603	7,090	6,371
Goodwill	19,950	20,548	22,650	23,222	23,550	24,518
Other Intangible Assets	3,326	3,659	2,621	2,710	2,529	1,979
Long-Term Deferred Tax Assets	-	5,064	5,408	4,955	5,178	5,352
Other Long-Term Assets	2	3	1	2	1	1
Total Assets	306,134	319,169	292,158	239,095	236,598	238,978
Accounts Payable	14,295	13,358	12,535	13,553	11,849	10,160
Accrued Expenses	2,882	22,727	6,722	5,497	4,718	5,032
Short-Term Debt	876	883	1,433	1,290	1,447	2,616
Current Portion of Long-Term Debt	-	-	-	-	-	298
Current Portion of Leases	-	203	169	156	160	100
Current Income Taxes Payable	1,252	17,417	18,479	12,143	12,471	12,802
Other Current Liabilities	27,439	1,117	15,137	13,024	11,614	11,577
Total Current Liabilities	46,744	55,705	54,475	45,663	42,259	42,585
Long-Term Debt	35,000	35,000	25,000	-	-	3,166
Long-Term Leases	-	468	433	403	375	383
Long-Term Deferred Tax Liabilities	-	1,903	1,854	1,287	906	793
Other Long-Term Liabilities	4,662	2,076	1,194	1,211	1,218	1,108
Total Liabilities	95,218	104,103	91,073	56,410	53,141	56,239
Common Stock	12,046	12,046	12,046	12,046	12,046	12,046
Additional Paid-In Capital	2,514	2,514	2,514	3,242	3,232	4,777
Retained Earnings	201,857	205,571	191,706	178,329	170,284	159,551
Treasury Stock	-24,783	-24,783	-24,972	-24,886	-12,959	-1,045
Comprehensive Income & Other	9,418	9,831	10,456	5,380	2,776	39
Total Common Equity	201,052	205,179	191,750	174,111	175,379	175,368
Minority Interest	9,864	9,887	9,335	8,574	8,078	7,371
Shareholders' Equity	210,916	215,066	201,085	182,685	183,457	182,739
Total Liabilities & Equity	306,134	319,169	292,158	239,095	236,598	238,978
Total Debt	35,876	36,554	27,035	1,849	1,982	6,563
Net Cash (Debt)	14,264	20,201	17,260	30,318	57,022	66,908
Net Cash Growth	65.34%	17.04%	-43.07%	-46.83%	-14.78%	-7.37%
Net Cash Per Share	114.17	161.71	138.19	236.35	430.35	500.61
Filing Date Shares Outstanding	124.94	124.94	124.88	124.92	129.12	133.64
Total Common Shares Outstanding	124.94	124.94	124.88	124.92	129.12	133.64
Working Capital	74,915	78,132	73,378	53,307	72,912	80,892
Book Value Per Share	1609.23	1642.26	1535.48	1393.73	1358.25	1312.24
Tangible Book Value	177,776	180,972	166,479	148,179	149,300	148,871
Tangible Book Value Per Share	1422.93	1448.51	1333.12	1186.15	1156.28	1113.97

Source: S&P Global Market Intelligence. Standard template. Financial Sources.